Senate Finance Committee Chairman Chuck Grassley insists that the long-delayed drug-price bill he is co-sponsoring will get a vote this year. Grassley worries that if the bill doesn't pass, drugmakers will charge whatever they want for Covid-19 related drugs. But drug lobbyists are counting on the coronavirus making drug pricing reform obsolete. Emma Court and Riley Griffin spoke to Senator Grassley about the bill.